Bank of Montreal’s Immunic IMUX Stock Holding History

Bank of Montreal’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10	Closed	-$1K	–	4748
2018 Q3	$1K	Buy	+10	New	+$26.1K	﹤0.01%	4543

Other funds holding IMUX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's IMUX Position: Q3 2024 in Review

Bank of Montreal sold out of Immunic (IMUX) in Q3 2024, closing a stake of 28,411 shares — an estimated $321K sold.

Bank of Montreal first reported a position in IMUX in Q4 2015 and held it in 13 quarters. The position peaked at $321K in Q2 2024. 61 funds tracked by Wall St. Rank hold IMUX as of Q3 2024.

Bank of Montreal reported no remaining Immunic position as of Q3 2024 after selling out during the quarter.
Bank of Montreal sold 28,411 Immunic shares in Q3 2024, an estimated $321K.
Bank of Montreal first reported a position in Immunic in Q4 2015 and held it in 13 quarters.
Bank of Montreal's Immunic position peaked at $321K in Q2 2024.
61 funds tracked by Wall St. Rank held Immunic as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.